Recent Cancer Treatment Linked to Worse COVID-19 Outcomes
A history of cancer more than 1 year before COVID-19 diagnosis not tied to increased mortality or hospitalization.
Cancer
Colonoscopy Before Age 50 May Cut Colorectal Cancer Risk in Women
Reduced risk seen with earlier initiation of endoscopy, including lower risk for colorectal cancer diagnosed in women before 55 years of age.
FDA Clears Automated, Wearable 3D Breast Ultrasound Device
In 2 minutes, the portable ATUSA system automatically scans the entire breast volume and provides 3D visualization of the breast tissue.
Ovarian Cancer is Not a Silent Killer – Recognizing Its Symptoms Could Help Reduce Misdiagnosis and Late Detection
Barbara Goff, MD discusses ovarian cancer and how recognizing symptoms can lead to early detection and reduce misdiagnosis.
Vitamin D Level, Race/Ethnicity Tied to Breast Cancer Risk
Sufficient circulating vitamin D concentration linked to lower risk for breast cancer in Hispanic/Latina women.
Prostate Cancer Biopsy, Diagnoses Down During the Pandemic
However, there were no statistically significant changes in rates by race.
COVID-19 Vaccine Largely Protects Cancer Patients
However, higher risk seen for breakthrough infections and severe outcomes, especially for hematologic malignancies.
False-Positive Mammograms Found in Half of Women Screened Annually
Clinicians should continue to counsel patients that false-positive results are an expected outcome of screening mammography. Age and breast density should be factored in when deciding the frequency of screening for average-risk women.
Top March 2022 FDA Approvals
March 2022 FDA approvals include treatments for Alzheimer disease, endometrial carcinoma, metastatic melanoma, and a genetic seizure disorder.
Cumulative Lifetime Excess Weight Has Bigger Impact on CRC Risk
Role of cumulative lifetime excess weight greater than role of excess BMI measured at a single time point.
- Loading...
Loading...
Next post in Oncology Information Center
Loading... 
Loading...